<noframes id="qmuuu"><option id="qmuuu"></option>
    • <tr id="qmuuu"><strike id="qmuuu"></strike></tr>
      全國(guó)服務(wù)咨詢熱線:

      18438616290

      Products產(chǎn)品中心
      首頁 > 產(chǎn)品中心 > 生化試劑 > 小分子化合物 > abs47028012Irbinitinib 937263-43-9

      Irbinitinib 937263-43-9

      簡(jiǎn)要描述:Irbinitinib 937263-43-9
      Irbinitinib(ARRY-380; ONT-380) is a potent and selective HER2 inhibitor with IC50 of 8 nM, equipotent against truncated p95-HER2, 500-fold more selective for HER2 versus EGFR.

      • 產(chǎn)品型號(hào):abs47028012
      • 廠商性質(zhì):生產(chǎn)廠家
      • 更新時(shí)間:2026-01-13
      • 訪  問  量:956

      詳細(xì)介紹

      品牌absinCAS937263-43-9
      分子式C26H24N8O2純度98%
      分子量480.52貨號(hào)abs47028012
      規(guī)格10mg供貨周期現(xiàn)貨
      主要用途is a potent and selective HER2 inhibitor應(yīng)用領(lǐng)域化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合

      Irbinitinib 937263-43-9

      產(chǎn)品描述
      描述
      Irbinitinib(ARRY-380; ONT-380) is a potent and selective HER2 inhibitor with IC50 of 8 nM, equipotent against truncated p95-HER2, 500-fold more selective for HER2 versus EGFR.
      純度
      98%
      儲(chǔ)存/保存方法
      Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
      基本信息
      可溶性/溶解性
      10 mM in DMSO
      生物活性
      靶點(diǎn)
      p95 HER2 ,ErbB2
      In vitro(體外研究)
      The compound is a reversible, ATP-competitive inhibitor with nanomolar potency against ErbB2 in both in vitro and in cell-based assays. Incell-based assays, ARRY-380 is ~500-fold selective for HER2 vs. EGFR and is equipotent against truncated p95-HER2.
      In vivo(體內(nèi)研究)
      In vivo, ARRY-380 significantly inhibits tumor growth in multiple HER2-dependent tumor xenograft models. It shows excellent activity in numerous mouse tumor models including breast (BT-474, MDA-MB-453), ovarian (SKOV-3) and gastric (N87) carcinoma models. In the BT-474 model, ARRY-380 demonstrated significant dose-related tumor growth inhibition (TGI; 50% at 50 mg/kg/d and 96% at 100 mg/kg/d) with numerous partial regressions (>50% reduction from baseline size).
      參考文獻(xiàn)
      參考文獻(xiàn)
      研究領(lǐng)域
      研究領(lǐng)域
      CancerTumor biomarkersOncoproteins
      CancerTumor immunologyTumor-associated antigens
      NeuroscienceDevelopment
      Signal TransductionProtein PhosphorylationTyrosine KinasesReceptor Tyrosine Kinases
      Tags & Cell MarkersCell Type MarkersTumor Associated
      Drug DiscoverySmall Molecule DrugLead Compound Discovery
      Irbinitinib 937263-43-9溫馨提示:本產(chǎn)品僅作科研實(shí)驗(yàn)使用,不支持臨床等研究

      產(chǎn)品咨詢

      留言框

      • 產(chǎn)品:

      • 您的單位:

      • 您的姓名:

      • 聯(lián)系電話:

      • 常用郵箱:

      • 省份:

      • 詳細(xì)地址:

      • 補(bǔ)充說明:

      • 驗(yàn)證碼:

        請(qǐng)輸入計(jì)算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7
      愛必信(上海)生物科技有限公司
      地址:上海市浦東新區(qū)新浩路58號(hào)申江科創(chuàng)園18棟
      傳真:
      關(guān)注我們
      歡迎您關(guān)注我們的微信公眾號(hào)了解更多信息:
      歡迎您關(guān)注我們的微信公眾號(hào)
      了解更多信息
      <noframes id="qmuuu"><option id="qmuuu"></option>
      • <tr id="qmuuu"><strike id="qmuuu"></strike></tr>
        最近中文字幕无码 | 日韩AV无码一区二区三区 | 日韩一级中文字幕 | 抠逼网站 | 国产在线色吧视频 | 男女污污污 | 国产人妻性生交大片 | 午夜婷婷免费观看 | 久久99高清 | 天天操BB|